nad has been researched along with Rhabdomyosarcoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Collins, VJ; Heske, CM; Holland, D; Issaq, SH; Ito, T; Ji, J; Karim, BO; Krishna, MC; Lee, U; Lei, H; McKay-Corkum, GB; Mendoza, A; Neckers, LM; Shern, JF; Thomas, CJ; Vulikh, K; Wilson, K; Yamamoto, K; Yeung, C; Yohe, ME; Zhang, Y | 1 |
Murray, MF; Nghiem, M; Srinivasan, A | 1 |
García-Cañero, R; Gosalvez, M; Reinhold, H | 1 |
3 other study(ies) available for nad and Rhabdomyosarcoma
Article | Year |
---|---|
Inhibition of NAD+-Dependent Metabolic Processes Induces Cellular Necrosis and Tumor Regression in Rhabdomyosarcoma Models.
Topics: Cell Line, Tumor; Cytokines; Humans; NAD; Necrosis; Nicotinamide Phosphoribosyltransferase; Pyrazoles; Rhabdomyosarcoma | 2023 |
HIV infection decreases intracellular nicotinamide adenine dinucleotide [NAD].
Topics: Cell Line; Cells, Cultured; HIV Infections; HIV-1; Humans; Lymphocyte Activation; Lymphocytes; NAD; Niacinamide; Rhabdomyosarcoma; Species Specificity; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Virus Replication | 1995 |
Delayed pyridine nucleotide reoxidation induced by the anticancer agent VM-26 as measured in vivo and in situ by NADH microfluorimetry.
Topics: Animals; Brain; Female; Fluorometry; Hypoxia; Mitochondria; NAD; Oxidation-Reduction; Oxygen Consumption; Podophyllotoxin; Rats; Rhabdomyosarcoma; Sarcoma, Experimental; Teniposide | 1975 |